HIV-1- Specific CD4 +T-cell responses are not associated with significant viral epitope variation in persons with persistent plasma viremia

Journal of Acquired Immune Deficiency Syndromes

Volumn 41, Issue 2, 2006, Pages 140-148

  Koeppe, John R ^a   Campbell, Thomas B ^a   Rapaport, Eric L ^a   Wilson, Cara C ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Antigenic variation; CD4 + T lymphocytes; HIV 1; Interferon

Indexed keywords

ANTIGEN P24; EPITOPE; GAG PROTEIN; GAMMA INTERFERON; HLA ANTIGEN CLASS 2; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; PROTEIN P17; VIRUS RNA; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; MATRIX PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1; VIRUS PROTEIN;

ADULT; AMINO ACID SEQUENCE; ANTIGEN RECOGNITION; ANTIGENIC VARIATION; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HLA TYPING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE DEPLETION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; VIREMIA; VIRUS LOAD; BIOSYNTHESIS; CELL CULTURE; CROSS-SECTIONAL STUDY; GENETIC VARIABILITY; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MIDDLE AGED; MOLECULAR GENETICS; SEQUENCE ALIGNMENT; VIROLOGY;

ADULT; AMINO ACID SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CROSS-SECTIONAL STUDIES; EPITOPES, T-LYMPHOCYTE; FEMALE; GENE PRODUCTS, GAG; HIV ANTIGENS; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON TYPE II; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT; VARIATION (GENETICS); VIRAL PROTEINS; VIREMIA;

EID: 33645284472     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000195608.32885.38     Document Type: Article

References (53)

1. Rosenberg ES, Billingsley JM, Caliendo AM, et al. Vigorous HIV-1-specific CD4+ cell responses associated with control of viremia. Science. 1997;21:1447-1450.
2. Boaz MJ, Waters A, Murad S, et al. Presence of HIV-1 gag-specific IFN-γ+IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection. J Immunol. 2002;169:6376-6385.
3. Alatrakchi N, Di Martino V, Thibault V, et al. Strong CD4 Th1 responses to HIV and hepatitis C virus in HIV-infected long term non-progressors co-infected with hepatitis C virus. AIDS. 2002;16:713-717.
4. Imami N, Pires A, Hardy G, et al. A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infection. J Virol. 2002;76:9011-9023.
5. Koup RA, Safrit JT, Cao Y, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type-1 syndrome. J Virol. 1994;68:4650-4655.
6. Borrow P, Lewicki H, Hahn BH, et al. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type-1 infection. J Virol. 1994;68:6103-6110.
7. Schmitz JE, Kuroda MJ, Santra S, et al. Control of viremia in simian immunodeficiency virus infected CD8+ lymphocytes. Science. 1999;283:857-860.
8. Jin X, Bauer DE, Tuttleton SE, et al. Dramatic rise in plasma viremia after CD8+ T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med. 1999;6:991-998.
9. Palmer BE, Boritz E, Wilson CC. Effects of sustained HIV-1 plasma viremia on HIV-1 gag-specific CD4+ T cell maturation and function. J Immunol. 2004;172:3337-3347.
10. Palmer BE, Boritz E, Blyveis N, et al. Discordance between frequency of human immunodeficiency virus type-1 (HIV-1)-specific gamma interferon-producing CD4+ T cells and HIV-1-specific lymphoproliferation in HIV-1-infected subjects with active viral replication. J Virol. 2002;76:5925-5936.
11. Younes SA, Yassine-Diab B, Dumont AR, et al. HIV-1 viremia prevents the establishment of interleukin-2 producing HIV-specific memory CD4+ T cells endowed with proliferative capacity. J Exp Med. 2003;198:1909-1922.
12. Betts MR, Ambrozak DR, Douek DC, et al. Analysis of total human immunodeficiency virus (HIV)-specific CD4+ and CD8+ T-cell responses to viral load in untreated HIV infection. J Virol. 2001;74:11983-11991.
13. Draenert R, Verrill CL, Tang Y, et al. Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type-1 infection. J Virol. 2004;78:630-640.
14. Migueles SA, Laborico AC, Imamichi H, et al. The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences. J Virol. 2003;77:6889-6898.
15. Migueles SA, Laborico AC, Shupert WL, et al. HIV-specific CD8+ T cell proliferation is coupled to perform expression and is maintained in nonprogressors. Nat Immunol. 2003;3:1061-1068.
16. Altfeld M, Addo MM, Shankarappa R, et al. Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences. J Virol. 2003;77:7330-7340.
17. Ostrowski MA, Gu JX, Kovacs C, et al. Quantitative and qualitative assessment of human immunodeficiency virus type-1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-γ and interleukin-10 responses. J Infect Dis. 2001;184:1268-1278.
18. Perelson AS, Neumann AU, Markowitz M, et al. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science. 1996;271:1582-1586.
19. Coffin JM. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science. 1995;267:483-489.
20. Soudeyns H, Paolucci S, Chappey C, et al. Selective pressure exerted by immunodominant HIV-1-specific cytotoxic T lymphocyte responses during primary infection drives genetic variation restricted to the cognate epitope. Eur J Immunol. 1999;29:3629-3635.
21. Birk M, Vahlne A, Sonnerborg A, et al. Nonsynonymous mutation within the human immunodeficiency virus type 1 p 17 gene are clustered to sequences binding to the host human leukocyte antigen class I molecules. AIDS Res Hum Retroviruses. 1998;14:241-248.
22. Barouch DH, Kunstman J, Kuroda MJ, et al. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature. 2002;415:335-339.
23. Wilson CC, Brown RC, Korber BT, et al. Frequent detection of escape from cytotoxic T-lymphocyte recognition in prenatal human immunodeficiency virus (HIV) type 1 transmission: the Ariel project for the prevention of transmission of HIV from mother to infant. J Virol. 1999;73:3975-3985.
24. Goulder PJ, Phillips RE, Colbert RA, et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med. 1997;3:212-217.
25. Cao J, McNevin J, Malhotra U, et al. Evolution of CD8+ T cell immunity and viral escape following acute HIV-1 infection. J Immunol. 2003;171:3837-3846.
26. Kelleher AD, Long C, Holmes EC, et al. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med. 2001;193:375-385.
27. Yang OO, Sarkis PT, Ali A, et al. Determinants of HIV-1 mutational escape from cytotoxic T lymphocytes. J Exp Med. 2003;197:1365-1375.
28. Jamieson BD, Yang OO, Hultin L, et al. Epitope escape mutation and decay of human immunodeficiency virus type 1-specific CTL responses. J Immunol. 2003;171:5372-5379.
29. Leslie AJ, Pfafferott KJ, Chetty P, et al. HIV evolution: CTL escape mutation and reversion after transmission. Nat Med. 2004;10:282-289.
30. Ciurea A, Hunziker L, Martinic MM, et al. CD4+ T-cell-epitope escape mutant selected for in vivo. Nat Med. 2001;7:793-800.
31. Harcourt GC, Garrard S, Davenport MP, et al. HIV-1 variation diminishes CD4 T-lymphocyte recognition. J Exp Med. 1998;188:1785-1793.
32. Brainard DM, Tharp WG, Granado E, et al. Migration of antigen-specific T cells away from CXCR4-binding human immunodeficiency virus type 1 gp120. J Virol. 2004;78:5184-5193.
33. Menzo S, Sampaolesi R, Vicenzi E, et al. Rare mutations in a domain crucial for V3-loop structure prevail in replicating HIV from long-term non-progressors. AIDS. 1998;12:985-997.
34. Wang FX, Kimura T, Nishihara K, et al. Emergence of autologous neutralization-resistant variants from preexisting human immunodeficiency virus (HIV) quasi species during virus rebound in HIV type 1-infected patients undergoing highly active antiretroviral therapy. J Infect Dis. 2002;185:608-617.
35. Malhotra U, Holte S, Zhu T, et al. Early induction and maintenance of Env-specific T-helper cells following human immunodeficiency virus type 1 infection. J Virol. 2003;77:2663-2674.
36. Matloubian M, Concepcion RJ, Ahmed R. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol. 1994;68:8056-8063.
37. Kalams SA, Buchbinder SP, Rosenberg ES, et al. Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection. J Virol. 1999;73:6715-6720.
38. Shedlock DJ, Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science. 2003;300:337-339.
39. Sun JC,Bevan MJ. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science. 2003;300:339-342.
40. Ciurea A, Hunziker L, Klenerman P, et al. Impairment of CD4+ T cell responses during chronic virus infection prevents neutralizing antibody responses against virus escape mutants. J Exp Med. 2001;193:297-305.
41. Noras PJ, Sumaroka M, Brander C, et al. Multiple effector functions mediated by human immunodeficiency virus specific CD4+ T-cell clones. J Virol. 2001;75:9771-9779.
42. Appay V, Zaunders JJ, Papagno L, et al. Characterization of CD4+ CTLs ex vivo. J Immunol. 2002;168:5954-5958.
43. Appay V. The physiological role of cytotoxic CD4+ T-cells: the holy grail? Clin Exp Immunol. 2004;138:10-13.
44. Douek DC, Brenchley JM, Betts MR, et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature. 2002;417:95-98.
45. Boritz E, Palmer BE, Livingston B, et al. Diverse repertoire of HIV-1 p24 specific FNF-γ producing CD4+ T-cell clones following immune reconstitution on highly active antitretroviral therapy. J Immunol. 2003;170:1106-1116.
46. Nei M, Gojobori T. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol. 1986;3:418-426.
47. Ota T, Nei M. Variance and covariances of the numbers of synonymous and nonsynonymous substitutions per site. Mol Biol Evol. 1994;11:613-619.
48. Los Alamos HIV Sequence Database. Available at: http://www.hiv.lanl. gov/content/hiv-db/SNAP/WEBSNAP/SNAP.html. Updated February 8, 2002.
49. Korber B. HIV signature and sequence variation analysis. In: Rodrigo AG, Learn GH, eds. Computational Analysis of HIV Molecular Sequences. Dordrecht, The Netherlands: Kluwer Academic Publishers; 2001:55-72.
50. Yusim K, Kesmir C, Gaschen B, et al. Clustering pattern of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type-1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation. J Virol. 2002;76:8757-8768.
51. Yoshimura FK, Diem K, Learn GH Jr, et al. Intrapatient sequence variation of the gag gene of human immunodeficiency virus type 1 plasma virions. J Virol. 1996;70:8879-8887.
52. Boritz E, Palmer B, Wilson CC. Human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cells that proliferate in vitro detected in samples from most viremic subjects and inversely associated with plasma HIV-1 levels. J Virol. 2004;78:12638-12646.
53. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 1995;373:117-122.